Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry

[1]  R. Mach,et al.  Selectivity of probes for PET imaging of dopamine D3 receptors , 2019, Neuroscience Letters.

[2]  Xingdang Liu,et al.  Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [18F]FP-(+)-DTBZ , 2018, Molecular Imaging and Biology.

[3]  S. Silverstein,et al.  Optical coherence tomography indices of structural retinal pathology in schizophrenia , 2017, Psychological Medicine.

[4]  T. Aleman,et al.  Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration , 2017, Neurology.

[5]  Evan D. Morris,et al.  Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis , 2017, Neurobiology of Aging.

[6]  H. Nasrallah,et al.  Multiple retinal anomalies in schizophrenia , 2017, Schizophrenia Research.

[7]  A. Lammertsma,et al.  Forward to the Past: The Case for Quantitative PET Imaging , 2017, The Journal of Nuclear Medicine.

[8]  M. Kim,et al.  Dopamine D3 receptor-modulated neuroprotective effects of lisuride , 2017, Neuropharmacology.

[9]  W. Wadsak,et al.  Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)‐11C-Verapamil PET , 2017, The Journal of Nuclear Medicine.

[10]  Mårtenn Sundberg,et al.  Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry , 2016, PloS one.

[11]  G. Zararsiz,et al.  Retinal Nerve Fiber Layer and Macular Thickness Measurement in Patients with Schizophrenia , 2016, European journal of ophthalmology.

[12]  Richard E. Carson,et al.  Age-related changes in binding of the D2/3 receptor radioligand [11C](+)PHNO in healthy volunteers , 2016, NeuroImage.

[13]  A. Simsek,et al.  Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: Findings from spectral optic coherence tomography , 2016, European Psychiatry.

[14]  J. Mukherjee,et al.  Dopamine D3 receptor binding of 18F‐fallypride: Evaluation using in vitro and in vivo PET imaging studies , 2015, Synapse.

[15]  S. Makin.  The Schizophrenia Spectrum , 2015 .

[16]  M. Quintanilla,et al.  Retinal nerve fiber layer and macular thickness in patients with schizophrenia: Influence of recent illness episodes , 2015, Psychiatry Research.

[17]  C. Missale,et al.  The D3 dopamine receptor: From structural interactions to function , 2015, European Neuropsychopharmacology.

[18]  B. Pollock,et al.  Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. , 2015, JAMA psychiatry.

[19]  E. Raviola,et al.  Extrasynaptic release of GABA and dopamine by retinal dopaminergic neurons , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[20]  A. Gingras,et al.  Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells. , 2015, Journal of proteomics.

[21]  B. Domon,et al.  Detection and quantification of proteins in clinical samples using high resolution mass spectrometry. , 2015, Methods.

[22]  Sylvain Houle,et al.  Lack of Age-Dependent Decrease in Dopamine D3 Receptor Availability: A [11C]-(+)-PHNO and [11C]-Raclopride Positron Emission Tomography Study , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  G. Searle,et al.  The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  N. Tian,et al.  Dopamine D2 receptors preferentially regulate the development of light responses of the inner retina , 2015, The European journal of neuroscience.

[25]  Alan A. Wilson,et al.  Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development , 2014, Front. Pharmacol..

[26]  M. Nebbioso,et al.  Role of the Dopaminergic System in the Development of Myopia in Children and Adolescents , 2014, Journal of child neurology.

[27]  E. Popova.  Role of dopamine in distal retina , 2014, Journal of Comparative Physiology A.

[28]  S. Kéri,et al.  Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: The potential impact of GABA concentration in the visual cortex , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  K. Palczewski,et al.  Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. , 2013, The Journal of clinical investigation.

[30]  W. Lee,et al.  Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. , 2013, Investigative ophthalmology & visual science.

[31]  Kristin S. Cadenhead,et al.  Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects , 2013, Front. Psychol..

[32]  Tiffany E. Chow,et al.  The potential role of dopamine D3 receptor neurotransmission in cognition , 2013, European Neuropsychopharmacology.

[33]  John D. Beaver,et al.  Mathematical modelling of [11C]-(+)-PHNO human competition studies , 2013, NeuroImage.

[34]  Yiyun Huang,et al.  Test-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm. , 2013, Molecular imaging.

[35]  Bin Fan,et al.  The D1 dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways , 2012, Molecular vision.

[36]  M. Ron,et al.  A window into the brain: An in vivo study of the retina in schizophrenia using optical coherence tomography , 2012, Psychiatry Research: Neuroimaging.

[37]  R. Palmiter,et al.  Retinal Dopamine Mediates Multiple Dimensions of Light-Adapted Vision , 2012, The Journal of Neuroscience.

[38]  Richard E Carson,et al.  Affinity and selectivity of [11C]‐(+)‐PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo , 2012, Synapse.

[39]  Sylvain Houle,et al.  Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO , 2011, Schizophrenia Research.

[40]  Mark Jenkinson,et al.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.

[41]  Mark Slifstein,et al.  In vivo binding of antipsychotics to D3 and D2 receptors: A PET study in baboons with [11C]-(+)-PHNO , 2010, NeuroImage.

[42]  John D. Beaver,et al.  Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist , 2010, Biological Psychiatry.

[43]  Xinqing Zhang,et al.  Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography , 2010, Neuroscience Letters.

[44]  E. Rabiner,et al.  In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO , 2011, Neuropsychopharmacology.

[45]  M. Laruelle,et al.  Imaging the D3 receptor in humans in vivo using [11C](+)-PHNO positron emission tomography (PET). , 2010, The international journal of neuropsychopharmacology.

[46]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[47]  Sylvain Houle,et al.  Side Effects Profile in Humans of 11C-(+)-PHNO, a Dopamine D2/3 Agonist Ligand for PET , 2010, Journal of Nuclear Medicine.

[48]  P. Marzullo,et al.  Single-Shot Cardiorenal Scintigraphy with 99mTc-Tetrofosmin: A Dynamic Characterization at Rest and During Adenosine Infusion , 2009, Journal of Nuclear Medicine.

[49]  Alan A. Wilson,et al.  The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO. , 2009, Archives of general psychiatry.

[50]  Alan A. Wilson,et al.  Side effects profile of [11C]-(+)-PHNO in human, a dopamine D2/3 agonist ligand , 2009 .

[51]  C. Ribelayga,et al.  The Circadian Clock in the Retina Controls Rod-Cone Coupling , 2008, Neuron.

[52]  Ariel Graff-Guerrero,et al.  Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humans , 2008, Human brain mapping.

[53]  A. Ventura,et al.  Müller Glia as an Active Compartment Modulating Nervous Activity in the Vertebrate Retina: Neurotransmitters and Trophic Factors , 2008, Neurochemical Research.

[54]  B. Skottun,et al.  Contrast sensitivity and magnocellular functioning in schizophrenia , 2007, Vision Research.

[55]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  Sylvain Houle,et al.  Positron Emission Tomography Quantification of [11C]-(+)-PHNO Binding in the Human Brain , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[57]  D. McMahon,et al.  Functional Heterogeneity of Retinal Dopaminergic Neurons Underlying Their Multiple Roles in Vision , 2007, The Journal of Neuroscience.

[58]  R. Narendran,et al.  Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]‐(+)‐PHNO is a D3 receptor preferring agonist in vivo , 2006, Synapse.

[59]  S. Kéri,et al.  Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[60]  Sylvain Houle,et al.  Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. , 2005, Journal of medicinal chemistry.

[61]  B. Thisse,et al.  Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[62]  W. Slaghuis,et al.  Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia , 2004, Experimental Brain Research.

[63]  Ken Nakayama,et al.  Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia. , 2003, The American journal of psychiatry.

[64]  Jeih-San Liow,et al.  Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  S. Zhang,et al.  Inhibition of glutamate-induced nitric oxide synthase activation by dopamine in cultured rat retinal neurons , 2003, Neuroscience Letters.

[66]  P. Fornaro,et al.  Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis , 2002, Documenta Ophthalmologica.

[67]  M. Wakakura.  [Experimental approaches to prophylactic neuroprotective treatment for retinal and optic nerve disorders]. , 2002, Nippon Ganka Gakkai zasshi.

[68]  P. Vernier,et al.  Dopamine receptor localization in the mammalian retina , 1999, Molecular Neurobiology.

[69]  A. Derouiche,et al.  The dopamine D2 receptor subfamily in rat retina: ultrastructural immunogold and in situhybridization studies , 1999, The European journal of neuroscience.

[70]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[71]  M. L. Veruki.  Dopaminergic Neurons in the Rat Retina Express Dopamine D2/3 Receptors , 1997, The European journal of neuroscience.

[72]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[73]  R. Beaurepaire,et al.  Evidence for a functional role of the dopamine D3 receptors in the cerebellum , 1996, Brain Research.

[74]  T. Oshika.  Ocular Adverse Effects of Neuropsychiatric Agents , 1995, Drug safety.

[75]  A. Reichenbach,et al.  Mammalian Müller (glial) cells express functional D2 dopamine receptors. , 1995, Neuroreport.

[76]  R. Todd,et al.  Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[77]  V. Tran,et al.  Differential localization of dopamine D1 and D2 receptors in rat retina. , 1992, Investigative ophthalmology & visual science.

[78]  H. Wagner,et al.  Localization and function of dopamine in the adult vertebrate retina , 1992, Neurochemistry International.

[79]  M. Caron,et al.  D2 dopamine receptors in the human retina: Cloning of cDNA and localization of mRNA , 1991, Cellular and Molecular Neurobiology.

[80]  T. Di Paolo,et al.  Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.

[81]  J. Nordmann,et al.  Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina , 1990, Neuroscience Letters.

[82]  J. Palacios,et al.  Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina , 1986, Brain Research.

[83]  P H Heintzen,et al.  Parametric imaging. , 1985, Radiologic clinics of North America.

[84]  A. Laties,et al.  Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.

[85]  J. Siddall.  The ocular toxic findings with prolonged and high dosage chlorpromazine intake. , 1965, Archives of ophthalmology.

[86]  Paul Witkovsky,et al.  Dopamine and retinal function , 2004, Documenta Ophthalmologica.

[87]  J. Joyce,et al.  Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons , 1999, Neuropsychopharmacology.

[88]  D L Hill,et al.  Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. , 1997, Medical physics.

[89]  Paul Witkovsky,et al.  Chapter 10 Functional roles of dopamine in the vertebrate retina , 1991 .

[90]  D. Weiner,et al.  Molecular cloning and expression of a dopamine D2 receptor from human retina. , 1990, Molecular pharmacology.